Determination of the Interaction between HER2 Receptor and Tomentosine by Molecular Docking
Abstract
Tomentosine and the HER2 gene are important molecules in cancer research. HER2 is a protein receptor on the cell surface that mediates cell growth signals. This protein encoded by the HER2 gene can cause excessive growth and spread of tumor cells, especially in some types of cancer such as breast cancer. Tomentosine, as a plant-derived compound, attracts attention with studies on its biological effects. The study evaluated the propensity of HER2 protein to bind to tomentosine and the therapeutic potential in cancer cases. The interactions of the molecules were analyzed using AutoDock 4.0. As a result, it was found that there is a multidirectional binding between HER2 and tomentosine, which was measured to be -8.47 (Gibbs free energy). These findings show that there is a high affinity and binding potential between HER2 protein and tomentosine. Therefore, it is thought that this study will provide a pioneer for future invitro studies.
Keywords
References
- Cheng, X. (2024). A Comprehensive Review of HER2 in Cancer Biology and Therapeutics. Genes, 15(7), 903. https://doi.org/10.3390/genes15070903.
- Güçlü, E., Çınar Ayan, İ., Dursun, H. G., & Vural, H. (2022). Tomentosin induces apoptosis in pancreatic cancer cells through increasing reactive oxygen species and decreasing mitochondrial membrane potential. Toxicology in vitro : an international journal published in association with BIBRA, 84, 105458. https://doi.org/10.1016/j.tiv.2022.105458
- He, J., Wu, H., Zhou, Y., & Zheng, C. (2020). Tomentosin inhibit cerebral ischemia/reperfusion induced inflammatory response via TLR4/ NLRP3 signalling pathway - in vivo and in vitro studies. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 131, 110697. https://doi.org/10.1016/j.biopha.2020.110697
- Husunet, M. T., Mısırlı, R. Ç., Istıflı, E. S., & Ila, H. B. (2022). Investigation of the genotoxic effects of patent blue V (E131) in human peripheral lymphocytes and in silico molecular docking. Drug and chemical toxicology, 45(4), 1780–1786. https://doi.org/10.1080/01480545.2021.1878208
- Jahanbin, B., Soleimani, V., Azmoude-Ardalan, F., Afshar, S., & Safaei, M. (2023). Evaluation of HER2 Gene Amplification using CISH in Patients with HER2 2+ (equivocal) Breast Carcinoma based on Immunohistochemistry in Imam Khomeini Cancer Institute from 2016 to 2018: HER2 amplification in breast carcinoma. Archives of Breast Cancer, 10(2), 131–137. https://doi.org/10.32768/abc.2023102131-137
- Lee, C. M., Lee, J., Nam, M. J., Choi, Y. S., & Park, S. H. (2019). Tomentosin Displays Anti-Carcinogenic Effect in Human Osteosarcoma MG-63 Cells via the Induction of Intracellular Reactive Oxygen Species. International journal of molecular sciences, 20(6), 1508. https://doi.org/10.3390/ijms20061508
- Merghoub, N., El Btaouri, H., Benbacer, L., Gmouh, S., Trentesaux, C., Brassart, B., Attaleb, M., Madoulet, C., Wenner, T., Amzazi, S., Morjani, H., & El Mzibri, M. (2017). Tomentosin Induces Telomere Shortening and Caspase-Dependant Apoptosis in Cervical Cancer Cells. Journal of cellular biochemistry, 118(7), 1689–1698. https://doi.org/10.1002/jcb.25826
- Paggi, J. M., Pandit, A., & Dror, R. O. (2024). The Art and Science of Molecular Docking. Annual review of biochemistry, 93(1), 389–410. https://doi.org/10.1146/annurev-biochem-030222-120000
- Park, H. H., Kim, S. G., Kim, M. J., Lee, J., Choi, B. K., Jin, M. H., & Lee, E. (2014). Suppressive effect of tomentosin on the production of inflammatory mediators in RAW264.7 cells. Biological & pharmaceutical bulletin, 37(7), 1177–1183. https://doi.org/10.1248/bpb.b14-00050
- Pathmanathan, N., & Bilous, A. M. (2012). HER2 testing in breast cancer: an overview of current techniques and recent developments. Pathology, 44(7), 587–595. https://doi.org/10.1097/PAT.0b013e328359cf9a.